Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1981 2
1982 2
1986 9
1987 2
1988 2
1989 1
1991 2
1992 2
1994 1
1995 1
1996 1
1997 3
1998 6
1999 7
2000 16
2001 8
2002 6
2003 14
2004 13
2005 32
2006 25
2007 19
2008 26
2009 21
2010 26
2011 15
2012 30
2013 29
2014 28
2015 32
2016 40
2017 65
2018 71
2019 71
2020 100
2021 95
2022 82
2023 83
2024 16

Text availability

Article attribute

Article type

Publication date

Search Results

906 results

Results by year

Filters applied: . Clear all
Page 1
Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: a post hoc analysis from ORAL Surveillance.
Charles-Schoeman C, Buch MH, Dougados M, Bhatt DL, Giles JT, Ytterberg SR, Koch GG, Vranic I, Wu J, Wang C, Kwok K, Menon S, Rivas JL, Yndestad A, Connell CA, Szekanecz Z. Charles-Schoeman C, et al. Among authors: kwok k. Ann Rheum Dis. 2023 Jan;82(1):119-129. doi: 10.1136/ard-2022-222259. Epub 2022 Sep 22. Ann Rheum Dis. 2023. PMID: 36137735 Free PMC article.
Radiology and COVID-19.
Chan JCX, Kwok KY, Ma JKF, Wong YC. Chan JCX, et al. Among authors: kwok ky. Hong Kong Med J. 2020 Aug;26(4):286-288. doi: 10.12809/hkmj205102. Hong Kong Med J. 2020. PMID: 32807735 Free article. No abstract available.
Long-term safety of tofacitinib up to 9.5 years: a comprehensive integrated analysis of the rheumatoid arthritis clinical development programme.
Cohen SB, Tanaka Y, Mariette X, Curtis JR, Lee EB, Nash P, Winthrop KL, Charles-Schoeman C, Wang L, Chen C, Kwok K, Biswas P, Shapiro A, Madsen A, Wollenhaupt J. Cohen SB, et al. Among authors: kwok k. RMD Open. 2020 Oct;6(3):e001395. doi: 10.1136/rmdopen-2020-001395. RMD Open. 2020. PMID: 33127856 Free PMC article. Clinical Trial.
Safety and efficacy of tofacitinib for up to 9.5 years in the treatment of rheumatoid arthritis: final results of a global, open-label, long-term extension study.
Wollenhaupt J, Lee EB, Curtis JR, Silverfield J, Terry K, Soma K, Mojcik C, DeMasi R, Strengholt S, Kwok K, Lazariciu I, Wang L, Cohen S. Wollenhaupt J, et al. Among authors: kwok k. Arthritis Res Ther. 2019 Apr 5;21(1):89. doi: 10.1186/s13075-019-1866-2. Arthritis Res Ther. 2019. PMID: 30953540 Free PMC article. Clinical Trial.
Society Guidelines-Where Is the Consensus?
Vitale DS, Kwok KK, Liu QY. Vitale DS, et al. Among authors: kwok kk. Gastrointest Endosc Clin N Am. 2020 Oct;30(4):763-779. doi: 10.1016/j.giec.2020.06.008. Epub 2020 Jul 30. Gastrointest Endosc Clin N Am. 2020. PMID: 32891231 Review.
Response.
Tien A, Kwok K. Tien A, et al. Among authors: kwok k. Gastrointest Endosc. 2020 Sep;92(3):797-798. doi: 10.1016/j.gie.2020.05.024. Gastrointest Endosc. 2020. PMID: 32838922 No abstract available.
Actionable targets to reduce COVID-19 severity.
Au Yeung SL, Luo S, Kwok KO. Au Yeung SL, et al. Among authors: kwok ko. Nat Metab. 2023 Feb;5(2):195-196. doi: 10.1038/s42255-023-00743-9. Nat Metab. 2023. PMID: 36805565 No abstract available.
906 results